Bynd Venture Capital

Bynd Venture Capital, established in 2010 and headquartered in Lisbon, Portugal, is a venture capital firm focusing on seed and early-stage investments. It primarily invests in Information Technology, Health (including Biotechnology and Digital Health), and Industrial/Consumer Goods sectors. The firm prefers to acquire minority stakes in companies based in Europe, particularly Portugal, and the United States. Bynd Venture Capital also considers investments in Sustainability, Clean Tech, and Life Sciences companies.

Lurdes Gramaxo

Partner, Executive Director

Martinho Matos

Investment Analyst

Maria Mesquita

Investment Associate and Platform Manager

Tomás Penaguião

Partner

Francisco Ferreira Pinto

Partner, Executive Director

Santiago Salazar

Co-Founder and Partner

Past deals in Architecture

Relive

Series A in 2025
Relive is a digital real estate platform that assists real estate consultants in creating, managing, and expanding their businesses. The platform offers comprehensive brokerage services for buying, selling, and renting properties, in addition to providing design and architecture projects, renovation and maintenance services, and credit consulting. By consolidating various aspects of the real estate journey, Relive aims to empower agents and foster the growth of successful real estate enterprises.

Relive

Pre Seed Round in 2022
Relive is a digital real estate platform that assists real estate consultants in creating, managing, and expanding their businesses. The platform offers comprehensive brokerage services for buying, selling, and renting properties, in addition to providing design and architecture projects, renovation and maintenance services, and credit consulting. By consolidating various aspects of the real estate journey, Relive aims to empower agents and foster the growth of successful real estate enterprises.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.